Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 205 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact205 DOIs

Add abstracts to 62 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact62 DOIs

Deposit reference lists for 19 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact19 DOIs

DOIs for this ISSN

Showing the top 5 of 621 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Challenges in β <sub>3</sub>… (10.1177/2042018811398517)	Abstract ORCID	102.65	112
2	Financial burden of diabetic foot ulcers to world: a progres… (10.1177/2042018817744513)	ORCID	60.78	269
3	GLP-1 receptor agonists: a review of head-to-head clinical s… (10.1177/2042018814559725)	ORCID	59.55	240
4	Review: Hydroxyoctadecadienoic acids: novel regulators of ma… (10.1177/2042018810375656)	ORCID	58.16	211
5	Review: Replication of cortisol circadian rhythm: new advanc… (10.1177/2042018810380214)	ORCID	58.11	210
6	Licorice abuse: time to send a warning message (10.1177/2042018812454322)	ORCID	57.74	203
7	Review of vancomycin-induced renal toxicity: an update (10.1177/2042018816638223)	ORCID	57.25	194
8	Autologous derived, platelet-rich plasma gel in the treatmen… (10.1177/2042018812438213)	Abstract ORCID	55.70	12
9	Anti-vascular endothelial growth factor therapy for diabetic… (10.1177/2042018813512360)	ORCID	55.30	162
10	Hyperglycemia in-hospital management (10.1177/2042018810397083)	Abstract ORCID	53.96	11
11	Review: Role of metformin in the management of polycystic ov… (10.1177/2042018810380215)	ORCID	53.81	141
12	Review: Endocrine and metabolic emergencies: thyroid storm (10.1177/2042018810382481)	ORCID	53.42	136
13	The obesity of bone (10.1177/2042018815611004)	ORCID	53.26	134
14	Current best practice in the management of patients after pi… (10.1177/2042018816687240)	ORCID	51.80	117
15	Clinically and pharmacologically relevant interactions of an… (10.1177/2042018816638050)	ORCID	51.03	109
16	Vitamin D and rheumatoid arthritis (10.1177/2042018812471070)	ORCID	50.73	106
17	Vitamin D and glycemic control in diabetes mellitus type 2 (10.1177/2042018813501189)	ORCID	49.67	96
18	Stimulation of incretin secreting cells (10.1177/2042018815618177)	ORCID	48.36	85
19	Therapeutic applications of melatonin (10.1177/2042018813476084)	ORCID	48.11	83
20	Current best practice in the management of Turner syndrome (10.1177/2042018817746291)	ORCID	48.11	83
21	Osteoporosis in liver disease: pathogenesis and management (10.1177/2042018816641351)	ORCID	47.98	82
22	The effects of old, new and emerging medicines on metabolic… (10.1177/2042018812437355)	ORCID	47.85	81
23	Clinical management of SIADH (10.1177/2042018812437561)	ORCID	47.58	79
24	A favorable effect of hydroxychloroquine on glucose and lipi… (10.1177/2042018814547204)	ORCID	47.16	76
25	Ghrelin is neuroprotective in Parkinson’s disease: molecular… (10.1177/2042018813479645)	ORCID	46.88	74
26	Management of amiodarone-related thyroid problems (10.1177/2042018811398516)	ORCID	46.73	73
27	Metabolic consequences of modern immunosuppressive agents in… (10.1177/2042018816641580)	ORCID	46.73	73
28	Pheochromocytoma – update on disease management (10.1177/2042018812437356)	ORCID	46.43	71
29	Levothyroxine treatment of mild subclinical hypothyroidism:… (10.1177/2042018815616543)	ORCID	45.97	68
30	Current best practice in the management of neuroendocrine tu… (10.1177/2042018818804698)	ORCID	45.65	66
31	Review: Testosterone and the metabolic syndrome (10.1177/2042018810390258)	ORCID	45.49	65
32	RETRACTED: PFKFB3, a key glucose metabolic enzyme regulated… (10.1177/2042018820923474)	Abstract References	45.15	7
33	Renal effects of dapagliflozin in patients with type 2 diabe… (10.1177/2042018814544153)	ORCID	44.81	61
34	Correlation between hemoglobin A1c and serum lipid profile i… (10.1177/2042018817692296)	ORCID	44.81	61
35	Current understanding of hypothalamic amenorrhoea (10.1177/2042018820945854)	ORCID	44.81	61
36	The role of adipokines in gestational diabetes mellitus (10.1177/2042018815577039)	ORCID	44.63	60
37	Vitamin D insufficiency and insulin resistance in obese adol… (10.1177/2042018814547205)	ORCID	44.27	58
38	The renal effects of SGLT2 inhibitors and a mini-review of t… (10.1177/2042018816676239)	ORCID	42.90	51
39	Review: Free fatty acid receptors: emerging targets for trea… (10.1177/2042018810381066)	ORCID	42.69	50
40	The metabolic syndrome: what’s in a name? (10.1177/2042018810374290)	Abstract ORCID	42.25	6
41	Interventions for the metabolic syndrome in schizophrenia: a… (10.1177/2042018812458697)	ORCID	42.25	48
42	Brugada ECG pattern during hyperkalemic diabetic ketoacidosi… (10.1177/2042018816680589)	Abstract ORCID	42.25	6
43	Efficacy and tolerability of glucagon-like peptide-1 recepto… (10.1177/2042018814558242)	ORCID	42.03	47
44	Current concepts in Graves’ disease (10.1177/2042018811408488)	ORCID	41.80	46
45	Effect of natural products on commercial oral antidiabetic d… (10.1177/2042018811411356)	ORCID	41.57	45
46	Thyroid cancer: pathogenesis and targeted therapy (10.1177/2042018811419889)	ORCID	41.33	44
47	Chemerin as an independent predictor of cardiovascular event… (10.1177/2042018816629894)	ORCID	41.09	43
48	Glycemic control among primary care patients with type 2 dia… (10.1177/2042018817742070)	ORCID	41.09	43
49	Therapeutic plasmapheresis for hypertriglyceridemia-associat… (10.1177/2042018817695449)	ORCID	40.84	42
50	Glucagon-like polypeptide agonists in type 2 diabetes mellit… (10.1177/2042018815580257)	ORCID	40.58	41